To further explore the relationship between MELK and miR-505-3p in HCC, we synthesized a miR-505-3p mimic to increase its expression level in HCC cells (Fig. 3F) and used a miR-505-3p inhibitor to effectively reduce the expression of miR-505-3p (Fig. 3G). Here, MELK is linked to hepatocellular carcinoma.